NCT07317349

Brief Summary

The purpose of this study is to investigate whether the experience of a daily time delay can affect our internal circadian rhythm.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
16mo left

Started Dec 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress22%
Dec 2025Aug 2027

First Submitted

Initial submission to the registry

December 19, 2025

Completed
1 day until next milestone

Study Start

First participant enrolled

December 20, 2025

Completed
16 days until next milestone

First Posted

Study publicly available on registry

January 5, 2026

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2027

Expected
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2027

Last Updated

January 16, 2026

Status Verified

December 1, 2025

Enrollment Period

1.2 years

First QC Date

December 19, 2025

Last Update Submit

January 14, 2026

Conditions

Keywords

circadian phase delayHealthy adults

Outcome Measures

Primary Outcomes (1)

  • Phase shift in circadian rhythm markers

    The primary outcome is the timing of dim light melatonin onset, a marker of circadian phase. Saliva samples will be collected at regular intervals under dim light, and the time when melatonin exceeds 3 pg/mL will be recorded for each participant. This allows measurement of circadian phase shifts across conditions.

    Comparing samples on days 1, 3, 5

Secondary Outcomes (1)

  • Psychomotor Vigilance Task (PVT) Median Reaction Time

    Performance will be measured at regular intervals on days 1 - 5 to track changes over the course of the study.

Study Arms (2)

Fixed daily routine

EXPERIMENTAL

All activities occur at the same time every day. During the five days, participants will have to complete various daily tests and also be asked to provide 8 saliva samples during days 1, 3, and 5

Behavioral: Fixed daily routine

Daily time delay of 1 hour

EXPERIMENTAL

All activities will be delayed by one hour. During the five days, participants will have to complete various daily tests and also be asked to provide 8 saliva samples during days 1, 3, and 5

Behavioral: Daily time delay

Interventions

All activities occur at the same time every day

Fixed daily routine

All activities will be delayed by one hour per day over a 5 day period.

Daily time delay of 1 hour

Eligibility Criteria

Age23 Years - 45 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy adults aged 23-45 years
  • Part of a heterosexual, cohabiting couple willing to participate together in a five-day in-laboratory study
  • Completion of at least upper-secondary education
  • Maintain a regular sleep-wake schedule
  • Habitual sleep timing within a normative range (non-extreme chronotype), assessed using the Morningness-Eveningness Questionnaire (MEQ) or the Munich Chronotype Questionnaire (MCTQ)
  • Both partners fall within the acceptable chronotype range to ensure aligned sleep-wake patterns
  • Low seasonality scores on the Seasonal Pattern Assessment Questionnaire (SPAQ)
  • Free from underlying sleep or mood disorders

You may not qualify if:

  • Engages in night-shift work or maintains an irregular work or sleep schedule
  • International travel involving a time-zone change of more than two hours within the past two months, or anticipated travel before study completion
  • Diagnosed neurological, psychiatric, or sleep disorder (e.g., insomnia, sleep apnea, bipolar disorder)
  • High risk of sleep apnea, defined as a Berlin Questionnaire score \>2 (Lauritzen et al., 2018)
  • Use of medications known to affect sleep, alertness, melatonin secretion, or circadian timing
  • Unable or unwilling to comply with behavioral restrictions, including refraining from electronic devices displaying time cues unless clocks are removed and devices are disconnected from Wi-Fi
  • Unable or unwilling to comply with consumption restrictions, including abstaining from caffeine, alcohol, and melatonin-rich foods during the study
  • Extreme chronotype, defined as a habitual midsleep time outside 03:00-05:00 on the MCTQ or classification as an extreme morning or extreme evening type on the MEQ
  • Daily caffeine consumption exceeding 400 mg (approximately 4-5 cups of coffee)
  • Current smoker or smoking within the past six months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Aarhus University, Department of Psychology and Behavioural Sciences

Aarhus, 8000, Denmark

RECRUITING

Related Links

Central Study Contacts

Ali Amidi, PhD

CONTACT

Alisha Guyett, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
Open-label, single-group basic science study; no masking used.
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Model Details: Participating couples will need to live in this environment for 5 consecutive days. By lottery draw, you as a couple will either be exposed to a fixed daily routine, where all activities occur at the same time every day, or a daily time delay of 1 hour, where all activities will be delayed by one hour.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 19, 2025

First Posted

January 5, 2026

Study Start

December 20, 2025

Primary Completion (Estimated)

March 1, 2027

Study Completion (Estimated)

August 30, 2027

Last Updated

January 16, 2026

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will share

De-identified individual participant data (IPD) underlying the published results will be shared with other researchers upon reasonable request, in accordance with Danish data protection regulations, institutional policies, and ethics approval. Data will be pseudonymised before sharing and no direct identifiers (e.g., name, contact details, personal ID numbers) will be included. Any data elements that could reasonably lead to re-identification in combination with other information will be removed or aggregated where necessary.

Shared Documents
STUDY PROTOCOL, SAP, ANALYTIC CODE
Time Frame
De-identified individual participant data and supporting documents will be made available beginning within 12 months after publication of the main results article and will remain available for at least 5 years thereafter.
Access Criteria
De-identified individual participant data (IPD), together with the study protocol, statistical analysis plan, and analytic code, will be available to qualified researchers affiliated with recognised research institutions who submit a methodologically sound proposal and obtain any required ethical or institutional approvals. Requests should describe the planned analyses and data needed. Approved requesters will sign a data use agreement prohibiting re-identification of participants and requiring appropriate data security. Data will be shared via secure transfer or a controlled-access repository approved by Aarhus University.

Locations